Cerofolini Linda, Amato Jussara, Borsi Valentina, Pagano Bruno, Randazzo Antonio, Fragai Marco
Giotto Biotech, Via Madonna del Piano 6, Sesto Fiorentino, Florence, 50019, Italy.
J Mol Recognit. 2015 Jun;28(6):376-84. doi: 10.1002/jmr.2452. Epub 2015 Feb 19.
DNA-minor-groove-binding ligands are potent antineoplastic molecules. The antibiotic distamycin A is the prototype of one class of these DNA-interfering molecules that have been largely used in vitro. The affinity of distamycin A for DNA is well known, and the structural details of the complexes with some B-DNA and G-quadruplex-forming DNA sequences have been already elucidated. Here, we show that distamycin A binds S100β, a protein involved in the regulation of several cellular processes. The reported affinity of distamycin A for the calcium(II)-loaded S100β reinforces the idea that some biological activities of the DNA-minor-groove-binding ligands arise from the binding to cellular proteins.
DNA小沟结合配体是有效的抗肿瘤分子。抗生素偏端霉素A是这类主要用于体外的DNA干扰分子中的一类的原型。偏端霉素A与DNA的亲和力是众所周知的,并且已经阐明了其与一些B-DNA和形成G-四链体的DNA序列的复合物的结构细节。在这里,我们表明偏端霉素A结合S100β,一种参与多种细胞过程调节的蛋白质。报道的偏端霉素A对钙离子负载的S100β的亲和力强化了这样一种观点,即DNA小沟结合配体的一些生物学活性源于与细胞蛋白的结合。